Competency category
Ethics and Boundaries
Professional ethics, therapeutic boundaries, consent for touch, and conduct in expanded states.
101 competencies, 47 with this as their primary category.
Looking for something specific? Ask Blossom
Primary competencies (47)
Competencies whose primary home is this category.
Therapeutic boundaries, professional conduct, and consent for touch
PrimaryTeaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.
8 care stages · 24 guidelines · 4 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreProfessional boundaries and recording consent
PrimaryTherapists may record sessions only with explicit participant consent and must handle recordings for training and research within protocol limits. Recording is part of the therapeutic and scientific framework, not routine clinical use.
5 care stages · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDMDMA+1 moreEthical psychedelic facilitation
PrimaryCluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.
8 care stages · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTIbogaineKetamine+1 moreProfessional self-care and burnout prevention
PrimaryTeaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.
6 care stages · 4 guidelines · 3 courses · 3 providers
KetamineMDMAPsilocybinTherapeutic touch judgment
PrimaryThe training includes appropriate use of therapeutic touch as part of safe delivery. Learners are expected to use touch judiciously and within ethical boundaries.
5 care stages · 4 guidelines · 1 courses · 1 providers
MDMAMaintain scientific and ethical caution in representing benefits
PrimaryBecause the paper notes limited conclusions about efficacy due to the crossover design, clinicians have an ethical responsibility to avoid overstating treatment effects. Competence includes accurately presenting the evidence base, uncertainty, and limits of inference to patients and colleagues.
2 care stages · 3 guidelines · 0 courses · 0 providers
KetamineLSDPsilocybinFacilitator self-awareness and self-care
PrimaryThe program includes facilitator development and self-care, and it explicitly calls on learners to recognize personal limitations and seek support. This suggests training in reflective practice and professional self-management.
4 care stages · 2 guidelines · 1 courses · 1 providers
DMT / AyahuascaMDMAPsilocybinEthical sourcing and ecological responsibility
PrimaryThe review explicitly discourages clinical development based on toad venom because of ethical and ecological concerns. Facilitators should favor synthetic sources and avoid practices that could harm wildlife or ecosystems.
2 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaProtection against coercion and dual-role influence
PrimaryThe protocol explicitly addresses the risk of undue influence when investigators recruit current or former patients, requiring safeguards and ongoing monitoring for coercion.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAProfessional Scope and Practice Alignment
PrimaryTeaches clinicians to recognise their role boundaries, align services with training, licensure, supervision, and organisational policy, and refer or escalate when participant needs fall outside their scope of competence.
5 care stages · 1 guidelines · 3 courses · 2 providers
IbogaineMDMAPsilocybinConfidentiality and trust maintenance
PrimaryThe course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.
5 care stages · 1 guidelines · 1 courses · 1 providers
LSDAddress transference and countertransference openly
PrimaryTherapists should be aware of transference and countertransference, which may be intensified in non-ordinary states. They are expected to respond with honesty, self-awareness, and openness rather than leaving important relational dynamics unspoken.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAAttention to participant experience and perceived coercion
PrimaryTherapists and research facilitators should evaluate how participants experienced study involvement, including perceived costs, benefits, and pressure to participate. This reflects an ethical responsibility to monitor the quality and voluntariness of participation over time.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMABoundary management in a dual-role therapeutic model
PrimaryNavigate the combination of psychedelic support and AUD therapy while preserving clear therapeutic boundaries. The facilitator must deliver supportive care without role confusion or undue influence.
3 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaBoundary-setting around external supports and media
PrimaryTherapists must help participants manage disclosure, social support, and media contact carefully to protect privacy and emotional safety. They should advise discretion without controlling the participant's choices.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMADetect and address unethical attitudes or behaviors
PrimaryTrainers and mentors observe therapists for conduct that could place participants at risk. Therapists must be receptive to correction and able to modify problematic behavior or seek additional training.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinDocumentation and note-taking
PrimaryDocument participant experiences and relevant observations to support continuity, recall, and study integrity. Notes may also serve as a participant memory aid after dosing sessions.
4 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinEthical handling of participant communication about future research
PrimaryManage optional future-contact procedures ethically and separately from current study participation. Participants may choose whether to authorize future contact without affecting present enrollment decisions.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinEthical honesty and transparency in management
PrimaryThe handbook emphasizes straightforward, honest dealing with subjects, especially when they feel suspicious, followed, or influenced. Trust is built by avoiding manipulation, deception, or concealed motives.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDEthical purpose and intention setting
PrimaryOrganizers should clarify the purpose of the session and the ethical means of achieving it. They should also encourage participants to prepare an intention in an ethical and responsible way.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaEthical risk communication
PrimaryCommunicates the experimental and unregulated nature of ibogaine treatment honestly. The source highlights an ibogaine subculture offering unregulated preparations, which creates an ethical duty to disclose uncertainty and risks.
2 care stages · 1 guidelines · 0 courses · 0 providers
IbogaineEthical supervision in experimental drug administration
PrimaryEnsure that administration occurs within an ethically supervised research or clinical framework with informed oversight and careful risk-benefit consideration. Hallucinogenic agents require especially cautious use in vulnerable psychiatric populations.
2 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaEthical use of nonstandard interventions
PrimaryUses a cautious, transparent ethical approach when working with an experimental or non-approved addiction treatment context.
1 care stage · 1 guidelines · 0 courses · 0 providers
IbogaineEthical use of psychoactive substances in therapy
PrimaryResponsibility to use LSD only within an ethically justified, clinically supervised framework. The source does not specify safeguards, but the therapeutic use of a potent psychoactive substance requires careful ethical oversight.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDLimits of confidentiality disclosure
PrimaryExplains the boundaries of confidentiality so patients understand when information may be disclosed without permission. Applies legal and ethical duties related to safety, abuse, and mandated reporting.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineManagement of dual relationships and undue influence
PrimaryTherapists must protect voluntariness when potential participants are also their patients. Independent evaluation should be used to reduce pressure or perceived coercion in recruitment and consent.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMAMedical boundary awareness
PrimaryNon-medical facilitators must not present themselves as medical professionals or provide medical advice. They should clearly state their limitations and encourage participants to consult their own healthcare providers when needed.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTNonjudgmental acceptance with firm boundaries
PrimaryTherapists are expected to offer deep acceptance of the person while not necessarily endorsing all acts or rationalizations. The handbook portrays therapeutic acceptance as compatible with clear interpersonal limits and reality-based feedback.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDOvernight support role boundaries
PrimaryAttendants and facilitators must maintain clear role boundaries, distinguishing supportive presence from psychotherapy or interpretation during overnight care.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAPatient rights advocacy
PrimaryFacilitators must uphold the Ibogaine Patient’s Bill of Rights, including dignity, privacy, access to information, and complaint processes. The provider should support interpretation and grievance handling when needed.
1 care stage · 1 guidelines · 0 courses · 0 providers
IbogainePermission for full expression
PrimaryParticipants must be given complete permission to express what arises without shame, fear, or guilt. The facilitator should accept the unfolding nonjudgmentally and avoid pathologizing it.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTProfessional conduct around sexuality and kundalini energy
PrimaryFacilitators may witness intense sensual, sexual, or kundalini energy but must respond professionally and without reciprocation or exploitation. Emotional maturity and decorum are required to protect participant vulnerability.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTRecognize and support vulnerability under altered states
PrimaryBecause participants may be more suggestible during psychedelic sessions, therapists must actively protect against manipulation and unsafe influence. This requires vigilance and careful conduct.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinResearch-professional role separation
PrimaryDistinguish psychotherapy/facilitation functions from outcome assessment and other research tasks. Separation reduces bias and protects the integrity of blinded assessments.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMASource extraction not possible
PrimaryThe provided source text does not contain the article content needed to identify therapist or facilitator competencies. It only includes a Wiley cookie/login page and site boilerplate.
1 care stage · 1 guidelines · 0 courses · 0 providers
IbogaineSupervision and self-reflection
PrimaryUse supervision, debriefing, and personal reflection to manage the intensity and complexity of IMAP work. Therapists need support to stay effective and ethically grounded.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport multiplicity without pathologizing
PrimaryTherapists should understand multiplicity, parts, selves, and related phenomena as often normal and especially relevant in trauma work. They must respond without pathologizing the participant’s awareness of different parts of self.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMATherapeutic boundary and contingency planning
PrimaryRespect patient autonomy while maintaining safety boundaries during a high-risk intervention. The protocol allowed return to opioid substitution therapy when clinically needed.
1 care stage · 1 guidelines · 0 courses · 0 providers
IbogaineEthics and ethical practice
PrimaryCluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.
8 care stages · 0 guidelines · 4 courses · 3 providers
MDMAPsilocybinProfessional application and practice development
PrimaryTeaches practitioners how to translate psychedelic-informed training into professional practice, including applied skill development, scope awareness, practice-building considerations, and integration of competencies into real clinical or wellness settings.
4 care stages · 0 guidelines · 2 courses · 2 providers
Complex-case support and ethics-based clinical judgment
PrimaryTeaches work with clinically complex contexts such as trauma, palliative care, and other nuanced presentations where ethical judgment, scope discipline, careful assessment, and individualized support are required.
3 care stages · 0 guidelines · 2 courses · 1 providers
PsilocybinEthical and equitable practice
PrimaryLearners are expected to follow the North Star Ethics Pledge and practice non-discrimination, equity, and inclusion. Ethical responsibility is positioned as a core professional competency.
2 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinEthical decision-making and confidentiality
PrimaryThe practicum explicitly says sites cover ethical considerations such as confidentiality, privacy, professional conduct, and ethical decision-making. Ethical alignment is also part of site approval.
2 care stages · 0 guidelines · 1 courses · 1 providers
Ethical grounding and integrity
PrimaryThe course repeatedly emphasizes ethical considerations, safety, and integrity in practice. Learners are expected to develop a grounded professional stance that respects legal boundaries and participant welfare.
3 care stages · 0 guidelines · 1 courses · 1 providers
Mentorship and professional development
PrimaryEach trainee works with a mentor, and mentoring includes professional development discussions, role plays, and networking. This indicates structured support for building practice readiness and professional identity.
3 care stages · 0 guidelines · 1 courses · 1 providers
Personal growth work and self-exploration
PrimaryStudents are expected to complete personal growth work outside the program, including therapy, guided entheogenic work, or meditation retreats. This signals the importance of self-awareness and personal preparation for facilitation work.
2 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinRespond ethically and relationally in crisis
PrimaryThe course explicitly includes ethical and relational considerations in crisis response. This suggests learners are trained to act with care, boundaries, and attunement when responding to acute distress.
3 care stages · 0 guidelines · 1 courses · 1 providers
Also mapped here (54)
Competencies that touch this category as a secondary axis.
Informed consent, decisional capacity, autonomy, and withdrawal rights
Teaches how to obtain and maintain valid informed consent through clear disclosure, comprehension checks, capacity support, voluntariness, non-coercion, and respect for refusal or withdrawal. The competency also covers consent for screening procedures, recordings, collateral contact, rescue interventions, and documentation of the consent process.
8 care stages · 59 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreCo-therapist and multidisciplinary team coordination
Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.
8 care stages · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreEthical conduct in human-subject research
Able to practice ethically in a clinical trial environment involving a Schedule-sensitive psychoactive intervention. This includes protecting participants, adhering to protocol, and supporting valid informed participation.
7 care stages · 16 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+3 moreEnsure confidentiality and session containment
Maintain a contained therapeutic environment that protects the patient’s privacy and minimizes unwanted exposure. The session structure emphasizes confidentiality and controlled access to stimulation and outside contact.
6 care stages · 9 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreCultural humility, Indigenous respect, and equity-oriented care
Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.
8 care stages · 7 guidelines · 11 courses · 10 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreTransference, countertransference, and therapist self-awareness
Teaches recognition and management of relational dynamics that can intensify in psychedelic-assisted therapy. Learners develop self-awareness around countertransference, projection, attachment, dependency, and other therapeutic-process risks.
6 care stages · 7 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineMDMA+1 moreSafe Therapeutic Container Creation
Teaches providers to create and maintain a psychologically and physically safe therapeutic setting through clear structure, preparation, boundaries, attunement, environmental design, and ongoing attention to participant safety.
5 care stages · 6 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreRespect autonomy and individualized communication preferences
Adapt language and interpersonal style to the patient’s preferences to promote dignity and comfort. The therapist should also respect the patient’s autonomy within safety limits.
4 care stages · 5 guidelines · 0 courses · 0 providers
IbogaineKetamineMDMA+1 moreWorking with inner healing intelligence
The course teaches how to work with the 'Inner Healing Intelligence,' indicating a non-directive or facilitative stance toward client-led healing processes. This is framed as a core therapeutic concept in psychedelic work.
4 care stages · 4 guidelines · 1 courses · 1 providers
MDMARecognize limits of evidence and avoid overstatement
Therapists and facilitators should communicate treatment effects responsibly and acknowledge methodological limitations. The paper notes small sample size, lack of long-term control group, and need for further study of mechanisms.
3 care stages · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDAttendant supervision and role clarity
Therapists must ensure attendants are appropriately selected and instructed for overnight monitoring. Attendants provide supportive care and observation without taking on psychotherapeutic functions.
3 care stages · 3 guidelines · 0 courses · 0 providers
MDMAPractice nondirective, participant-led facilitation
A core competency is following rather than steering the participant’s process, intervening only in service of the unfolding inner-directed experience.
2 care stages · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinVoluntary participation and non-coercion
The handbook explicitly states that the experience should be fully explained and that the subject should accept it voluntarily. Coercion is framed as both unethical and therapeutically counterproductive.
4 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineLSDClinical supervision participation
Engages in ongoing supervision and accepts feedback to maintain treatment quality. Supports corrective action when performance is unsatisfactory.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinCoordinate with outside providers ethically
Therapists must coordinate with prescribing clinicians and existing psychotherapists when relevant, while respecting consent and confidentiality. Communication should support safety, continuity, and protocol integrity.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAFunction effectively as a therapy pair
Where co-therapy is used, therapists should work cohesively, remain present, and respect participant preferences within the dyad.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAMaintain beginner’s mind
Therapists should cultivate openness about both the participant’s process and their own interpretations. This prevents forcing experience into rigid theoretical frames and supports curiosity and compassion.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMANeutral, unbiased facilitation
The facilitator must minimize bias in how assessments are administered and in how participant responses are handled. This is important because the trial is open-label and relies heavily on patient-reported outcomes.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetamineMDMAProfessional licensure and supervision
Therapists must meet licensure requirements and work within supervision structures appropriate to their training and role. Unlicensed or PAP-inexperienced staff require direct supervision.
3 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinProfessional qualification and supervised practice
Lead therapists must hold appropriate licensure and regulatory registration to provide psychotherapy, and have prior PAP experience. Unlicensed or inexperienced therapists may participate only under direct supervision.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinTherapist availability and time commitment
Therapists must be prepared for an extensive and sometimes unpredictable commitment of time and support. Ethical delivery includes reliable availability beyond scheduled sessions when participants need additional help.
2 care stages · 2 guidelines · 0 courses · 0 providers
LSDMDMACollaborative choice-making
Work collaboratively with the patient, sharing observations and options while preserving the patient’s authority over their process. This supports empowerment in the context of trauma-related loss of control.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMACollaboratively address trauma material
Therapists should obtain agreement that trauma may be gently brought up if not spontaneously addressed, while preserving participant choice and collaborative exploration.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMACommunicate risks, benefits, and alternatives
The investigator/therapist has ethical responsibility to explain study goals, course, expected effects, possible advantages and disadvantages, risks, and alternative treatments in verbal and written form. This includes ensuring participant questions are answered satisfactorily and that there is enough time for decision-making.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDDyadic facilitation and gender-balanced therapeutic presence
Experimental sessions are conducted by a male physician-investigator and an experienced female nurse, indicating competency in co-therapy, complementary roles, and continuous therapeutic presence.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAEthical use of reassurance
Provide reassurance when it helps establish safety, while avoiding invalidation or minimization. Reassurance should support rather than dismiss the patient’s experience.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAHandling rationalization and resistance
A major therapist task is detecting and not reinforcing rationalizations that protect the existing self-concept. The handbook portrays resistance as subtle and expects the therapist to respond firmly but without hostility.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDIdentity and values reconstruction
Facilitators must support the bereaved person in rebuilding identity and future orientation after loss. The protocol uses values clarification to help participants orient life around their own goals and surviving self.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaInclusivity and non-discrimination in participant engagement
Therapist/facilitator practice in the study must align with equity, diversity, and inclusion commitments by avoiding exclusions based on protected or social identity characteristics outside protocol-defined scientific/safety criteria. This supports ethically sound participant engagement.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinInformed consent and ethical use in uncertain evidence
Use ibogaine only after a careful discussion of uncertain efficacy, limited research, and known risks. Ethical practice requires transparent communication about the experimental nature of treatment and the absence of robust clinical standards.
3 care stages · 1 guidelines · 0 courses · 0 providers
IbogaineInformed consent boundary awareness
Study personnel involved with participants must understand informed consent responsibilities and boundaries. Consent is an ongoing process, and appropriately trained staff without an existing clinical relationship obtain consent, not the PI.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinManaging self-examination and core therapeutic work
The therapist must support the subject through difficult self-scrutiny without taking over the process, distracting prematurely, or colluding with avoidance. This phase is described as the central therapeutic component where emotional insight and acceptance emerge.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDParticipant-centered inclusion and non-discrimination
The protocol explicitly frames equity, diversity, and inclusion as ethical requirements. Facilitators should deliver care and study procedures without discrimination on race, ethnicity, religion, sex, or gender.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinProfessional ethics and policy adherence
Adheres to organizational code of ethics, privacy policy, electronic communication policy, and applicable laws. Maintains professional conduct across contractor and clinic arrangements.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetaminePsychotherapy discussion and support
Provides required discussion of psychotherapy before randomization and supports continuation of clinically indicated non-study psychotherapy. Documents participant choice and any psychotherapy-related decisions.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineRecognition of limitations and uncertainty in psychedelic support
Facilitators should be aware that outcome variability may reflect both drug effects and psychological support effects. The source notes that fidelity was not assessed, underscoring the need for humility and careful practice.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinRecruitment and contact ethics
Ability to recruit participants using approved procedures while respecting privacy, documented preferences, and limits on contact attempts. Recruitment must avoid coercion and unauthorized disclosure.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineRelational field attunement
Attend closely to the therapeutic relationship as an active part of the healing process. IMAP treats the relational field as a primary site where trauma, repair, trust, and connection unfold.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASafety attunement
Maintain physical, emotional, and relational safety as the primary guiding principle throughout IMAP. Therapists continuously monitor risk, reinforce boundaries, and intervene more directly when safety is compromised.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAStructured psychiatric screening collaboration
Understands the screening instruments and the respective roles of site staff and independent raters. The facilitator must collaborate with rater findings while maintaining appropriate boundaries and blinding.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAValidate affirming experiences as healing
Therapists should validate positive, affirming, and resourcing experiences as meaningful components of healing, growth, and meaning-making.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMAValidate difficult experiences as healing
Therapists should frame difficult emotions, challenging material, and distressing experiences as potentially meaningful parts of healing rather than signs of failure.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMAWork skillfully with resistance and protective mechanisms
Therapists should respect defenses, protectors, and resistance as potentially adaptive rather than obstacles to be forcibly overcome. The skill lies in fostering awareness and curiosity about protection while minimizing retraumatization.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMACase-based practice, peer consultation, and professional learning community
Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.
8 care stages · 0 guidelines · 8 courses · 7 providers
KetaminePsilocybinExperiential Learning and Reflective Practice
Teaches practitioners to use experiential exercises, embodied awareness, supervision, and structured self-reflection to examine their own reactions, assumptions, limits, and relational patterns in clinical work.
3 care stages · 0 guidelines · 2 courses · 2 providers
Collaborative work with adjunctive clients
Learners are taught how to work with clients who already have an outside therapist and to coordinate closely with existing treatment. The course also mentions treatment flow for groups and couples.
5 care stages · 0 guidelines · 1 courses · 1 providers
KetamineCollaborative-care role awareness
The program emphasizes that it prepares people for therapeutic and facilitative roles within a collaborative care framework, not independent medical practice. Learners are expected to understand role boundaries, especially around prescribing and administration.
5 care stages · 0 guidelines · 1 courses · 1 providers
KetaminePsilocybinLeadership and coaching presence in expanded states
Faculty and program structure emphasize leadership, coaching presence, and personal transformation as part of practitioner development. Students are expected to become more skillful in guiding high-achieving and growth-oriented clients.
4 care stages · 0 guidelines · 1 courses · 1 providers
Peer-informed clinical judgment
The course emphasizes learning from experienced trainers and a community of peers, suggesting development of clinical judgment through discussion, feedback, and shared practice. This is framed as part of building competence in an evolving field.
1 care stage · 0 guidelines · 1 courses · 1 providers
Reciprocity and ecological awareness
Reciprocity and ecological awareness are named as a core knowledge domain. This indicates training in relational responsibility, environmental context, and respectful exchange with communities and traditions.
1 care stage · 0 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreSafety and legal boundaries awareness
The page includes explicit warnings about what graduates can and cannot legally do. Learners are expected to understand scope limits, licensure requirements, and when consultation supervision is needed.
3 care stages · 0 guidelines · 1 courses · 1 providers
KetamineMDMAPsilocybinSafety, ethics, and responsibility in expanded states work
The course explicitly states that facilitators are guided in safety, ethics, and responsibility. Learners are expected to recognize and manage the unique risks of working with altered states.
6 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinSpace preparation and ceremonial setup
Practicum hours may include operational tasks like preparing rooms, setting up altars, and arranging ceremonial spaces. These are treated as part of hands-on professional competence.
3 care stages · 0 guidelines · 1 courses · 1 providers
Tracking nervous systems and consent dynamics
The Colorado practicum site explicitly teaches relational competence, including tracking nervous systems, power, and consent dynamics moment by moment. This is presented as a core facilitation capability.
4 care stages · 0 guidelines · 1 courses · 1 providers
Psilocybin
Other categories
Explore the rest of the competency taxonomy.